NOOR ALAINA: Open Payments
NPI 1518317304 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,613 in 127 payments from 28 companies in 2025. Trend: 2023 $1,377 · 2024 $1,433 · 2025 $2,613
Food & beverage: $2,601Education: $12
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 17 | $426 |
| Amgen Inc. | 12 | $364 |
| Novo Nordisk Inc | 10 | $229 |
| Mannkind Corporation | 15 | $198 |
| Corcept Therapeutics | 14 | $197 |
| Xeris Pharmaceuticals, Inc. | 11 | $166 |
| Abbott Laboratories | 9 | $149 |
| SANOFI-AVENTIS U.S. LLC | 5 | $130 |
| Neurocrine BioSciences, Inc. | 4 | $93 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $74 |
Products named: MINIMED 780G, TEPEZZA, AFREZZA, Korlym, FREESTYLE LIBRE 3, TZIELD, Ozempic, EVENITY.
Industry payments across TX — which companies pay providers there.
